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Background: Epidemiological investigations have indicated that Helicobacter pylori induces inflammation in the
gastric mucosa regulated by several interleukins. The genes IL1B and IL8 are suggested as key factors in determining
the risk of gastritis. The aim of this paper was to evaluate the association of gene polymorphism of interleukin-1
and interleukin-8 with chronic gastrits in H. pylori infected patients. A total of 60 patients underwent endoscopic
procedure. Biopsy samples were collected for urease test, histopathological and molecular exams. The DNA of
theses samples was extracted for detection of H. pylori and analysis of the genes mentioned above. Patients with
gastritis had a higher frequency of H. pylori-positive samples.
Results: H. pylori was detected in 30/60 patients (50%) by PCR. As for polymorphism of interleukin 8 (−251) gene
we observed a statistical difference when analyzed TA (p = 0.039) and TT (p = 0.047) genotypes. In the IL1B31 there was
a statistical difference in TT (p = 0.01) genotype and in the IL1B-511 there wasn’t any statistical difference.
Conclusion: Our results suggest a strong correlation between the presence of chronic gastritis and infection by H.
pylori and that IL1B-31TT and IL8-251TT genotypes appear to act as protective factors against H. pylori infection while
IL8-251TA genotype may comprise a risk factor for infection with this bacterium.
Keywords: Helicobacter pylori, Polymorphism, InterleukinBackground
Helicobacter pylori is a gram-negative bacterium that
colonizes the gastric antrum and/or the body of the
human stomach, causing complications such as gastritis,
gastric and duodenal ulcer and gastric malignancies
[1,2]. H. pylori is present in approximately half of the
world population [3]. Numerous studies have shown a
significant relationship between the bacteria and the risk
of gastritis [4,5]. Atherton [6] reported that the develop-
ment of gastric diseases is influenced by the degree of
virulence of the H. pylori strain, the host genetic suscep-
tibility and environmental cofactors.
Some virulence factors, such as vacA and cagA genes,
were studied since they could play an important role in* Correspondence: slmpayao@famema.br
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article, unless otherwise stated.the pathogenesis of infection with H. pylorii. The vacA
gene, present in all strains, covers two different regions,
the “s” region (s1 and s2) and the “m” region (m1 and
m2) [7]. Another relevant marker of pathogenicity is the
cagA gene, present in about 60-70% of the H. pylori
strains. Infection with H. pylori cagA + strains have been
associated with a greater degree of inflammation of the
gastric mucosa and severe atrophic gastritis. Therefore,
it has been suggested to play an important role in the
development of gastric carcinoma [7,8].
Chronic infection with H. pylori results in inflamma-
tion of the gastric mucosa, which induces the expression
of proinflammatory cytokines such as interleukins, tumor
necrosis factor (alpha), and interferon [9].
Several genetic polymorphisms related to inflamma-
tory cytotoxins have been studied and associated with an
increase in the synthesis of these interleukins. The poly-
morphisms of some interleukins are important in cancerCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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the activation of an inflammatory cascade of cytotoxins,
which induces the production of chemokines for neutro-
phils and mononuclear cells, as well as interleukins IL8
and IL1, leading to a response with an inflammatory
infiltrate and development of chronic gastritis [12]. The
IL8 gene has been described as having a polymorphism
of an A/T base pair in the promoting region (−251)
which is associated with an increase in the synthesis of
interleukin by gastric epithelial cells [13,14].
The presence of -31CC or -511TT genotypes of inter-
leukin 1B may render patients at increased risk of devel-
oping gastric atrophy and hypochlorhydria by infection
of H. pylori, which can also lead to a two- to threefold
increased risk of malignancy compared to the presence
of less inflammatory genotypes [15,16]. Cytokine IL1B-
31CC/-511TT gene polymorphisms have been shown to
be related to gastric cancer and chronic gastritis devel-
opment in patients infected by H. pylori. [16,17]. There-
fore, the aim of this paper was to evaluate association of
gene polymorphisms of interleukin 1 and 8 with chronic
gastrits in H. pylori infected patients.Methods
Patients and samples
Thirty adults (mean age 49.5 years old) that tested posi-
tive for H. pylori infection and had recurrent abdominal
pain were included in the present study. Control group
comprised 30 individuals in the same age group. All
subjects were recruited from the Endoscopy Unit of
Marilia Medical School, SP, Brazil. Demographics of
these patients were obtained from medical records. Three
biopsy samples from each patient were collected from
the gastric antrum in order to be submitted for histo-
pathological examination, rapid urease test and DNA
extraction.
All patients or legal guardians were informed about
the objectives and the research protocol of the present
study. They all signed an informed consent form approved
by the Research Ethics Committee of Marília Medical
School (protocol n. 1119/11).DNA extraction and H. pylori detection
DNA was extracted from the gastric biopsies using the
QIAamp® tissue kit (Qiagen, Germany) according to the
manufacturer’s instructions. For the detection of H. pyl-
ori the PCR technique was employed, which amplifies a
fragment of 150 bp from the 16S rRNA of H. pylori [18].
PCR conditions comprised 40 cycles of amplification,
each cycle consisted of 45 seconds of denaturation at
94°C, 45 seconds of annealing at 59°C and 45 seconds
extension at 72°C. In each experiment, positive (strain
26695) and negative (water) controls were included.Histopathology and rapid urease test
The fragments were fixed with 10% formalin and stained
by hematoxylin-eosin and Giemsa. Microscopic examin-
ation defined the degree of involvement of the gastric
mucosa and presence of Helicobacter pylori.
An antral biopsy from each patient was incubated in
premade broth (TUPF; Laborclin, Brazil) for the urease
test immediately after collection. The test was consid-
ered positive when the color of the solution changed
from yellow to orange, pink, or purple within four hours
of incubation at 25°C.
Interleukin-1β genotyping
In order to characterize IL1β (−31,-511) gene polymorph-
ism, restriction fragment length polymorphism (RFLP)
was employed. Similarly, polymorphism of the promoting
region (−511) in the IL1β gene was identified using PCR
primers under the conditions described by Wilkinson
et al. [19]. AvaI enzyme was used to digest the PCR prod-
ucts at 37°C overnight. Electrophoresis in 3% agarose gel
stained with ethidium bromide showed the following
bands: CC (80 and 109 bp), CT (80, 109 and 189 bp) and
TT (189 bp).
To the promoting region (−31) of the IL1β gene the
AluI enzyme was used for digestion at 37ºC overnight
[15]. The following bands, separated by electrophoresis
in 3% agarose gel stained with ethidium bromide, were
observed: CC (240 bp); CT ( 98, 137 and 240 bp) and
TT (98 and 137 bp) [20].
Interleukin-8 genotyping
IL8 (−251) gene polymorphisms were characterized
through RFLP as previously described [21]. The PCR
product, a 349-bp fragment, was digested by MunI re-
striction enzyme (MBI Fermentas, Canada) overnight
at 37°C and then separated by electrophoresis in 3%
agarose gel stained with ethidium bromide. The diges-
tion fragments had 349 bp with TT genotype, 202 and
147 bp with AA genotype and 349, 202 and 147 bp
with TA genotype.
Results
Helicobacter pylori was detected in 30 of the 60 patients
(50%) by PCR whereas the urease test detected the bac-
terium in 21 patients (35%) (Table 1). All the samples in
which the histology and urease test demonstrated the
presence of H. pylori were also positive by PCR, showing
a sensitivity of 65% and specificity of 100% by PCR and
sensitivity of 43.5% and specificity of 92.9% by rapid
urease test. The histopathological analysis revealed the
presence of chronic gastritis in 46 subjects (76.6%).
In relation to the distribution of IL1B-511 polymor-
phisms, no significant difference was observed in geno-
type distribution among patients infected with H. pylori
Table 1 PCR and urease test detection for H. pylori in
patients with chronic gastritis and negative control
group
Chronic gastritis
PCR Negative (%) Positive (%) Total
Positive 0 (0) 30 (100)* 30
Negative 14 (46.7) 16 (53.3) 30
Urease Negative Positive Total
Positive 1 (4.8) 20 (95.2)* 21
Negative 13 (33.3) 26 (66.7) 39
*Statistical difference was observed.
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distribution of genotype IL1B-31 was analyzed, a signifi-
cant difference was found. Frequency of TT genotype
was lower in H. pylori-infected patients (6.7%) when
compared with the non-infected group (33.3%, p = 0.01).
When IL8-251 polymorphisms were analyzed, a signifi-
cant variation was found. The distribution of TA geno-
type was higher in H. pylori-infected patients (63.3%)
than in the control group (36.7%, p = 0.039) whereas the
frequency of TT genotype was higher in controls (43.3%)
than in infected patients (20%, p = 0.047). These results
of polymorphisms are displayed in Table 2.
Discussion
In the present study, we analyzed gene polymorphisms
of IL8 and IL1B together with H. pylori infection in
groups of adult patients from Marília, SP, Brazil. Re-
cently, researchers have been focusing their attention on
the possible connection between human gene polymor-
phisms and H. pylori infection. From the investigated
genes, it is important to emphasize the role of proinflam-
matory IL-1 polymorphism (IL1B-511 T/-31C), demon-
strated in experiments conducted by El-Omar et al. [15].
In the Japanese population, IL1B-511C >C polymorph-
ism was dominant among patients with advanced atro-
phic chronic gastritis, whereas IL1B-511 T > T + T >C
polymorphism was more frequent in the Chinese popu-
lation. In addition, no differences were found in the
frequency of occurrence of C and T alleles in Tai and
Vietnamese populations [22]. Regarding the Chinese
case, interesting observations have shown that the IL1B-
511TT genotype disclosed an association between pepticTable 2 Genotype distribution of single nucleotide polymorp
to PCR results for H. pylori infection
PCR IL1B-31 IL1B-5
CC (%) TC (%) TT (%)* Total CC (%) TC (%
Pos. 10 (33.3) 18 (60) 2 (6.7) 30 11 (36.7) 13 (43
Neg. 5 (16.7) 15 (50) 10 (33.3) 30 10 (33.3) 16 (53
*Statistical difference was observed.disease and H. pylori [23]. Santos et al. [24] found that
in the Brazilian population, IL1β-511CC and CT gene
polymorphisms were associated with chronic gastritis
and gastric cancer development in H. pylori-infected
individuals. Our results of patients non-infected and
infected with H. pylori revealed no association with
IL1B-511 polymorphisms.
The Chinese research also found that IL1B-31CC geno-
type was more frequent in carcinoma patients than in the
control group in northern China (a region characterized
by high incidence of gastric carcinoma), whereas in south-
ern China (a region with low gastric carcinoma incidence)
it was more frequent in controls than in cancer patients
[23]. This indicates that the T allele could act as a proin-
flammatory allele in genotype IL1B-31 T and both geno-
types may constitute independent gastric carcinoma risk
factors. These hypotheses were corroborated by investiga-
tions carried out in Korea, which indicated the importance
of H. pylori infection and presence of IL1B-31 T and IL1B-
511C polymorphism for the increase of IL1B production
by the gastric mucosa [25]. Our results suggest that the
genotype IL1B-31TT emerge as a possible protector factor
against H. pylori. Similar results were found in Turkish
patients [26].
Cheng et al. [27] found no association of polymor-
phisms of IL8-251 T > A with increased risk of gastritis
in Thai patients, as well as Fabris et al. [28] who did not
find any significant association between IL-8-251 T > A
polymorphism and H. pylori infection in Brazilian pa-
tients. However, some studies reported controversial
results. Hofner et al. [29] described an association be-
tween IL8 (TA) genotype and risk for gastritis or duodenal
ulcers in patients infected with H. pylori. Ohyauchi et al.
[11] and Taguchi et al. [13] observed that the AA geno-
type confers higher risk for atrophic gastritis compared to
the TT genotype in patients with H. pylori. These authors
also associated TA and AA genotypes with augmented
levels of IL8 and higher degree of neutrophil infiltration
when compared with the TT genotype.
In the present study, we found a significant difference
between TA and TT genotypes of IL8 and the presence
of H. pylori. However, such relation was not true for the
AA genotype, which suggests that the presence of TA
genotype may be a risk factor H. pylori infection whereas
TT genotype may act as a protector factor against H.hisms of IL1B and IL8 in Brazilian adult patients according
11 IL8-251
) TT (%) Total AA (%) TA (%)* TT (%)* Total
.3) 6 (20) 30 5 (16.7) 19 (63.3) 6 (20) 30
.3) 4 (13.4) 30 6 (20) 11 (36.7) 13 (43.3) 30
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the A allele in the promoting region (−251) of the IL8
gene was related to an increased risk of stomach malig-
nancy [11,13,30]. According to some studies, production
of IL8 is augmented by the presence of A allele, and the
quality and intensity of inflammatory responses pro-
duced by the host can be altered after exposure to
H. pylori [13,14,30].
The discrepancy among IL8 genotypes may be related
to genetic differences in populations and sample sizes.
However, the frequency of IL-8-251 TA genotype was
found to be different among ethnic groups as reported
in the single nucleotide polymorphism database (http://
www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=4073).
Polymorphisms of IL8 are biologically important in
the pathogenesis of gastric diseases. Therefore, further
studies in different populations are required, since these
polymorphisms in some demographic regions appear to
be essential in the development of gastric diseases. Our
results showed a significant role of polymorphisms of
genes IL1 and IL8 in relation to the infection by H.
pylori and the development of gastric mucosa inflamma-
tion. It is necessary to bear in mind that gene polymor-
phisms of other cytokines and other genetic factors may
exert a synergistic action in the development of such
changes related to H. pylori.
Conclusion
In summary, the current results suggest a strong correl-
ation between the presence of chronic gastritis and infec-
tion by H. pylori. In addition, the IL1B-31TT and IL8-251
TT genotypes seem to act as protective factors against
H. pylori infection while IL8-251TA genotype may be a
risk factor for infection with this bacterium. These poly-
morphisms are biologically important in the pathogenesis
of gastric diseases and require more studies in different
populations, since they appear to be an important variable
in the development of gastric diseases in some individuals
exposed to H. pylori.
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